Skip to main content

Table 1 Histolopathogical and molecular characteristics of cancer in a cohort of 231 Saudi breast cancer patients

From: Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients

Histologic type LUMA No.(%) LUMB No(%) HER2 No(%) Basal No(%) Hybrid No(%) UC N0(%) Total No(%)
IDC 6 (3.3) 27 (14.8) 29 (15.8) 20 (10.9) 16 (8.7) 85 (46.4) 183 (79.2)
ILC 3 (33.3) 5 (55.6) 0 (0) 0 (0) 0 (0) 1 (11.1) 9 (3.89)
ISC 0 (0) 3 (20.) 7 (46.7) 0 (0) 3 (20) 2 (13.3) 15 (6.49)
other* 0 (0) 2 (8.3) 4 (16.7) 3 (12.5) 4 (16.7) 11(45.8) 24 (10.38)
  1. IDC = Invasive ductal carcinoma-NOS, ILC = Invasive lobular carcinoma, ISC = In situ carcinoma, LUMA = luminal A, LUMB = luminal B, HER2 = human epidermal growth factor receptor 2, UC = unclassified
  2. *Include medullary carcinoma, mixed ductal and lobular carcinoma, metaplastic carcinoma, apocrine carcinoma and juvenile secretory carcinoma